MedPath

Fluid Resuscitation in Septic Shock Patients With BMI Elevation

Not Applicable
Terminated
Conditions
Septic Shock
Obesity
Sepsis
Interventions
Procedure: Ideal Body Weight Dosing
Procedure: Adjusted Body Weight Dosing
Procedure: Actual Body Weight Dosing
Registration Number
NCT04759989
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.

Detailed Description

Early, goal-directed therapy with timely achievement of hemodynamic stability has been shown to clearly improve outcomes in patients with septic shock. Although Surviving Sepsis Campaign guidelines recommend a weight-based approach to initial fluid resuscitation (i.e. 30ml/kg),1 at present, there are no robust data to support whether dosing based on actual body weight or an alternative correction formula (ideal body weight, adjusted body weight) is superior.

FRISSBE is a prospective, randomized, three-arm parallel-group pilot trial of alternative resuscitation strategies for obese patients with septic shock, looking at feasibility and safety of different weight-based approaches. Subject treatment assignment will not be blinded. Data will be collected and analyzed on an intent-to-treat basis. The study will enroll 60 subjects, with 20 subjects per treatment arm. Subjects will be randomized to receive one of three weight-based initial fluid resuscitation strategies - 30cc/kg ideal body weight (IBW), 30cc/kg adjusted body weight (AdjBW), or 30cc/kg actual body weight (ABW).

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • 18 years of age or older

  • BMI > 30

  • suspected infection, and either:

    • hypotension (a systolic blood pressure < 90mmHg) or
    • blood lactate concentration > 4mmol/L
Read More
Exclusion Criteria
  • Pregnant
  • Primary diagnosis of acute cerebral vascular event
  • Acute coronary syndrome
  • Acute pulmonary edema
  • Status asthmaticus
  • Major cardiac arrhythmia
  • Active gastrointestinal hemorrhage
  • Seizures
  • Drug overdose
  • Burns or trauma
  • Requirement for immediate surgery
  • CD4<50/mm3
  • Do-not-resuscitate order status
  • Transferred from another hospital
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
30cc/kg ideal body weight (IBW)Ideal Body Weight Dosing30cc/kg intravenous fluids based on the patients calculated ideal body weight will be administered when randomized to this arm Using Devine's formula. (men: 50kg + 2.3kg \* (height(in) - 60); women: 45.5kg + 2.3kg \* (height(in) - 60)
30cc/kg adjusted body weight (AdjBW)Adjusted Body Weight Dosing30cc/kg intravenous fluids based on the patients calculated adjusted body weight will be administered when randomized to this arm Calculated by the following formula: AdjBW = IBW + 0.4(ABW - IBW).
30cc/kg actual body weight (ABW)Actual Body Weight Dosing30cc/kg intravenous fluids based on the patients actual body weight will be administered when randomized to this arm Patients will receive an initial fluid bolus of 30 cc/kg of actual body weight
Primary Outcome Measures
NameTimeMethod
Safety-time to hemodynamic stability72 hours

time from randomization to map \>65 without use of vasopressors and no lactate \>2

Feasibility1: fluid target3 hours

percentage of of patients with actual volume received within 10% of target fluid volume.

Safety-vasopressors24 hours

proportion of patients requiring vasopressor administration

Safety-ventilation24 hours

Proportion of patients requiring invasive or noninvasive mechanical ventilation

Secondary Outcome Measures
NameTimeMethod
feasibility2: recruitment ratestudy duration

proportion of patients enrolled out of patients screened to randomized through completion of study, an average of 1 year

Exploratory: in-hospital all cause mortality28 days

Proportion of patient in each group who experience death due to any cause during hospitalization up to 28 days

Exploratory: ICU length of stay28 days

number of consecutive midnights in ICU

feasibility3: time to randomization3 hours

median time from screening to randomization

Exploratory: hospital length of stay28 days

number of midnights spent in hospital up to 28 days

Trial Locations

Locations (1)

Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath